Intellectual Property
Intelectual Property (IP)
USPTO Announces Request for Comments: AI’s Impact on Prior Art and the PHOSITA | Jones Day
The USPTO is seeking public input on whether prior art must be authored by humans and how, if at all, AI-generated disclosures should be treated ...
Intelectual Property (IP)
The Case for Using Filing Dates Instead of Expiration Dates to Determine Obviousness-Type Double Patenting (Part I)
“The best course of action would be to eliminate ODP altogether. However, to the extent that is not feasible, there is an easy solution that ...
Intelectual Property (IP)
USPTO Issues Notice of Proposed Rulemaking On Discretionary Denial, Serial and Parallel Petitions, and Settlement | Jones Day
On April 19, 2024, the USPTO issued a Notice of Proposed Rulemaking (the “Notice”) regarding discretionary denial in post-grant proceedings and other issues. The Notice ...
Intelectual Property (IP)
USITC Commissioner Series: The Court’s FRAND Dance May Soon Reach its Finale | Axinn, Veltrop & Harkrider LLP
This is part five of our USITC Commissioner Series. Read part one here, part two here, part three here and part four here. In prior ...
Intelectual Property (IP)
Plead Your Case, Not Your Secrets: A Discussion of Recent Trade Secret Complaints | Proskauer – Trade Secrets
Taking legal action to protect a trade secret is unlike other intellectual property litigation since what you’re trying to protect is a secret. Plaintiffs must ...
Intelectual Property (IP)
USPTO Requests Comments Regarding AI’s Impact | WilmerHale
USPTO Requests Comments Regarding Artificial Intelligence’s Impact on Prior Art, Person Having Ordinary Skill in the Art, and Patentability On April 30, 2024, the United ...
Intelectual Property (IP)
North Carolina Trade Secret Protections Laws Do Not Apply to Out-of-State Conduct | Parker Poe Adams & Bernstein LLP
Like most states, North Carolina law protects employers from misappropriation of confidential and proprietary trade secrets. Last month, the North Carolina Business Court (a division ...
Intelectual Property (IP)
Race Against the Clock: Federal Agencies Issue Their Six-Month Updates on AI Activities in Accordance With President Biden’s Executive Order on AI | Faegre Drinker Biddle & Reath LLP
Since President Biden issued his sweeping Executive Order on the Safe, Secure and Trustworthy Development of AI on October 30 of last year (EO), federal ...
Intelectual Property (IP)
Biosimilar Launch and Approval Updates – Tyenne® (tocilizumab-aazg), Xlucane™ (ranibizumab), Hercessi™ (trastuzumab-strf) | Venable LLP
First Actemra® Biosimilar Launch – Fresenius Kabi’s Tyenne® (tocilizumab-aazg) On April 15, 2024, Fresenius Kabi announced the U.S. launch of Tyenne® (tocilizumab-aazg), the first Actemra® (tocilizumab) biosimilar ...